The Valley Desk

NCT03522246 · Interventional trial

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Overall registry status Active not recruiting

Phase 3

Conditions Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov